Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term extension study of lesinurad plus allopurinol in gout
2012-004389-16Phase 3Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lesinurad in gout, sponsored by Ardea Biosciences, Inc. Primary endpoint: Proportion of subjects achieving serum uric acid target. Started Apr 2013; status: completed.
02
Drugs
lesinurad
03
Conditions
gout
Beyond the preview
Go deeper on 2012-004389-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004389-16.